EverCrisp apple
Selected indexed studies
- Single-molecule live-cell RNA imaging with CRISPR-Csm. (Nat Biotechnol, 2025) [PMID:39966655]
- Targeted delivery of genome editors in vivo. (Nat Biotechnol, 2026) [PMID:41526513]
- Genome integrity sensing by the broad-spectrum Hachiman antiphage defense complex. (Cell, 2024) [PMID:39395413]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Single-molecule live-cell RNA imaging with CRISPR-Csm. (2025) pubmed
- Targeted delivery of genome editors in vivo. (2026) pubmed
- Genome integrity sensing by the broad-spectrum Hachiman antiphage defense complex. (2024) pubmed
- Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein. (2025) pubmed
- Rapid DNA unwinding accelerates genome editing by engineered CRISPR-Cas9. (2024) pubmed
- In vivo site-specific engineering to reprogram T cells. (2026) pubmed
- Directed evolution expands CRISPR-Cas12a genome-editing capacity. (2025) pubmed
- Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing. (2025) pubmed
- Packaged delivery of CRISPR-Cas9 ribonucleoproteins accelerates genome editing. (2025) pubmed
- Viral delivery of an RNA-guided genome editor for transgene-free germline editing in Arabidopsis. (2025) pubmed